Business Standard

Monday, December 23, 2024 | 02:16 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Coronavirus: How worried should we be about the Omicron variant?

Omicron's mutations are likely to render certain COVID-19 treatments - including some manufactured antibodies - ineffective

Photo: Bloomberg
Premium

Photo: Bloomberg

Reuters
The new Omicron coronavirus variant - identified first in South Africa, but also detected in Europe and Asia - is raising concern worldwide given the number of mutations, which might help it spread or even evade antibodies from prior infection or vaccination.

News of the variant prompted countries to announce new travel restrictions on Friday and sent drugmakers scrambling to see if their COVID-19 vaccines remain protective.

WHY ARE SCIENTISTS WORRIED?

The World Health Organization on Friday classified the B.1.1.529 variant, or Omicron, as a SARS-CoV-2 "variant of concern," saying it may spread more quickly than other forms of coronavirus.

The Delta variant remains

Disclaimer: No Business Standard Journalist was involved in creation of this content

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in